Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to $5.3 million.

  • Stemtech's Accounts Payables rose 798.39% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 798.39%. This contributed to the annual value of $4.5 million for FY2024, which is 6679.76% up from last year.
  • Latest data reveals that Stemtech reported Accounts Payables of $5.3 million as of Q3 2025, which was up 798.39% from $5.2 million recorded in Q2 2025.
  • In the past 5 years, Stemtech's Accounts Payables ranged from a high of $5.3 million in Q3 2025 and a low of $1.4 million during Q3 2022
  • Over the past 5 years, Stemtech's median Accounts Payables value was $3.8 million (recorded in 2024), while the average stood at $3.8 million.
  • In the last 5 years, Stemtech's Accounts Payables tumbled by 4897.03% in 2022 and then skyrocketed by 8929.75% in 2023.
  • Over the past 5 years, Stemtech's Accounts Payables (Quarter) stood at $4.1 million in 2021, then dropped by 16.15% to $3.4 million in 2022, then dropped by 20.25% to $2.7 million in 2023, then surged by 66.8% to $4.5 million in 2024, then increased by 18.24% to $5.3 million in 2025.
  • Its Accounts Payables stands at $5.3 million for Q3 2025, versus $5.2 million for Q2 2025 and $4.9 million for Q1 2025.